Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Other Non-Current Liabilities (2017 - 2025)

Selectis Health's Other Non-Current Liabilities history spans 12 years, with the latest figure at $106300.0 for Q4 2025.

  • Quarterly results put Other Non-Current Liabilities at $106300.0 for Q4 2025, up 9.7% from a year ago — trailing twelve months through Dec 2025 was $106300.0 (up 9.7% YoY), and the annual figure for FY2025 was $106300.0, up 9.7%.
  • Other Non-Current Liabilities for Q4 2025 was $106300.0 at Selectis Health, up from $104800.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $318750.0 in Q1 2024 to a low of $85150.0 in Q2 2024.
  • The 5-year median for Other Non-Current Liabilities is $245840.5 (2021), against an average of $211974.8.
  • The sharpest move saw Other Non-Current Liabilities rose 26.92% in 2022, then tumbled 71.65% in 2024.
  • Year by year, Other Non-Current Liabilities stood at $229582.0 in 2021, then rose by 26.92% to $291388.0 in 2022, then increased by 7.33% to $312750.0 in 2023, then plummeted by 69.02% to $96900.0 in 2024, then increased by 9.7% to $106300.0 in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $106300.0, $104800.0, and $102800.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.